[go: up one dir, main page]

FI970534L - Förfaranden och kompositioner som är användbara vid profylax och behandling av endotoxinrelaterade tillstånd - Google Patents

Förfaranden och kompositioner som är användbara vid profylax och behandling av endotoxinrelaterade tillstånd Download PDF

Info

Publication number
FI970534L
FI970534L FI970534A FI970534A FI970534L FI 970534 L FI970534 L FI 970534L FI 970534 A FI970534 A FI 970534A FI 970534 A FI970534 A FI 970534A FI 970534 L FI970534 L FI 970534L
Authority
FI
Finland
Prior art keywords
compositions
preventing
methods
related conditions
treating endotoxin
Prior art date
Application number
FI970534A
Other languages
English (en)
Finnish (fi)
Other versions
FI118035B (sv
FI970534A0 (sv
Inventor
Daniel M Levine
Thomas S Parker
Albert L Rubin
Bruce R Gordon
Stuart D Saal
Original Assignee
Rogosin Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26965092&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI970534(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/288,568 external-priority patent/US5506218A/en
Application filed by Rogosin Inst filed Critical Rogosin Inst
Publication of FI970534L publication Critical patent/FI970534L/sv
Publication of FI970534A0 publication Critical patent/FI970534A0/sv
Application granted granted Critical
Publication of FI118035B publication Critical patent/FI118035B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1275—Lipoproteins or protein-free species thereof, e.g. chylomicrons; Artificial high-density lipoproteins [HDL], low-density lipoproteins [LDL] or very-low-density lipoproteins [VLDL]; Precursors thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Dispersion Chemistry (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI970534A 1994-08-10 1997-02-07 Kompositioner som är användbara vid profylax och behandling av endotoxinrelaterade tillstånd FI118035B (sv)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US08/288,568 US5506218A (en) 1992-08-12 1994-08-10 Methods useful in endotoxin based therapy
US28856894 1994-08-10
US08/487,459 US5674855A (en) 1992-08-12 1995-06-07 Methods and compositions useful in prophylaxis and therapy of endotoxin related conditions
US48745995 1995-06-07
US9510189 1995-08-10
PCT/US1995/010189 WO1996004916A1 (en) 1994-08-10 1995-08-10 Methods and compositions useful in prophylaxis and therapy of endotoxin related conditions

Publications (3)

Publication Number Publication Date
FI970534L true FI970534L (sv) 1997-02-07
FI970534A0 FI970534A0 (sv) 1997-02-07
FI118035B FI118035B (sv) 2007-06-15

Family

ID=26965092

Family Applications (1)

Application Number Title Priority Date Filing Date
FI970534A FI118035B (sv) 1994-08-10 1997-02-07 Kompositioner som är användbara vid profylax och behandling av endotoxinrelaterade tillstånd

Country Status (27)

Country Link
US (1) US5674855A (sv)
EP (1) EP0767666B1 (sv)
JP (1) JP3818660B2 (sv)
CN (1) CN1137688C (sv)
AP (1) AP782A (sv)
AT (1) ATE255415T1 (sv)
AU (1) AU703861C (sv)
BG (1) BG61967B1 (sv)
BR (1) BR9508584A (sv)
CA (1) CA2196906C (sv)
CY (1) CY2514B1 (sv)
CZ (1) CZ287614B6 (sv)
DE (1) DE69532239T2 (sv)
DK (1) DK0767666T3 (sv)
ES (1) ES2211915T3 (sv)
FI (1) FI118035B (sv)
HK (1) HK1003709A1 (sv)
HU (1) HUT77605A (sv)
NO (1) NO313786B1 (sv)
NZ (1) NZ292315A (sv)
OA (2) OA11737A (sv)
PL (1) PL182043B1 (sv)
PT (1) PT767666E (sv)
RO (1) RO115782B1 (sv)
RU (1) RU2174839C2 (sv)
SK (1) SK282493B6 (sv)
WO (1) WO1996004916A1 (sv)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6518412B1 (en) 1997-09-29 2003-02-11 Jean-Louis Dasseux Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
US6046166A (en) 1997-09-29 2000-04-04 Jean-Louis Dasseux Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
US6037323A (en) 1997-09-29 2000-03-14 Jean-Louis Dasseux Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
US6004925A (en) 1997-09-29 1999-12-21 J. L. Dasseux Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
AU3809900A (en) * 1999-03-09 2000-09-28 Max-Delbruck-Centrum Fur Molekulare Medizin Therapy and use of compounds in therapy
US20030032674A1 (en) * 2001-08-13 2003-02-13 Hwang Daniel H. Use of unsaturated fatty acids to treat severe inflammatory diseases
BR0310099A (pt) 2002-05-17 2007-03-20 Esperion Therapeutics Inc método para tratar dislipidemia ou uma doença associada com a dislipidemia
WO2004068969A1 (en) * 2003-02-05 2004-08-19 N.V. Nutricia Enteral composition for the prevention and/or treatment of sepsis
HUE038247T2 (hu) * 2004-05-19 2018-10-29 Los Angeles Biomedical Res Inst Harbor Ucla Medical Ct Nátrium-deoxikolátot tartalmazó injektálható készítmény
US7754230B2 (en) * 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
US20060127468A1 (en) * 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
NZ565590A (en) * 2005-08-29 2010-07-30 Sepsicure L L C Use of a protein free composition comprising cholinic acid and a phosphosphlipid for the treatment or prevention of conditions caused by gram-positive bacteria
GB0522942D0 (en) 2005-11-10 2005-12-21 Leigh Steven Dissolution composition
EP2537526A1 (en) 2006-06-01 2012-12-26 Institut de Cardiologie de Montréal Method and compound for the treatment of valvular stenosis
KR100785656B1 (ko) * 2007-05-14 2007-12-17 재단법인서울대학교산학협력재단 소염제로 사용되는 소디움글리코콜레이트 또는 그 유도체
PL2396017T3 (pl) 2009-02-16 2015-12-31 Cerenis Therapeutics Holding Sa Mimetyki apolipoproteiny A-l
US8101593B2 (en) 2009-03-03 2012-01-24 Kythera Biopharmaceuticals, Inc. Formulations of deoxycholic acid and salts thereof
EP2675460A4 (en) 2011-02-18 2014-07-09 Kythera Biopharmaceuticals Inc TREATMENT OF FAT TISSUE UNDER CHIN
US8653058B2 (en) 2011-04-05 2014-02-18 Kythera Biopharmaceuticals, Inc. Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits
US9023833B2 (en) * 2012-12-18 2015-05-05 Sepsicure, LLC Method for treating sepsis in patients with albumin, cholesterol and HDL levels above minimum thresholds

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4115313A (en) * 1974-10-08 1978-09-19 Irving Lyon Bile acid emulsions
DE2556592C2 (de) * 1975-12-16 1986-10-09 A. Nattermann & Cie GmbH, 5000 Köln Arzneimittelzubereitungen auf Basis öliger Lösungen von Phospholipiden
US4314997A (en) * 1980-10-06 1982-02-09 Edward Shanbrom Purification of plasma protein products
IL63734A (en) * 1981-09-04 1985-07-31 Yeda Res & Dev Lipid fraction,its preparation and pharmaceutical compositions containing same
CA1237671A (en) * 1983-08-01 1988-06-07 Michael W. Fountain Enhancement of pharmaceutical activity
JPS6193111A (ja) * 1984-05-28 1986-05-12 Funayama Seizo 発熱性物質除去方法
US5032585A (en) * 1987-02-17 1991-07-16 Board Of Regents, The University Of Texas System Methods and compositions employing unique mixtures of polar and neutral lipids for surfactant replacement therapy
CA2013755C (en) * 1989-04-05 1993-11-30 Simon Benita Medicinal emulsions
DE4017979A1 (de) * 1990-06-05 1991-12-12 Meyer Lucas Gmbh & Co Lipid- bzw. phospholipid-zusammensetzungen sowie diese enthaltendes mittel zur behandlung von erkrankungen sowie auf die zellmembrane zurueckzufuehrende stoerungen
BR9201168A (pt) * 1992-04-02 1994-04-12 Zerbini E J Fundacao Microemulsoes usadas como velculo para carregar quimioterapicos as celulas neoplasicas

Also Published As

Publication number Publication date
AP782A (en) 1999-11-15
ES2211915T3 (es) 2004-07-16
RU2174839C2 (ru) 2001-10-20
AU3405295A (en) 1996-03-07
CA2196906C (en) 2004-03-02
RO115782B1 (ro) 2000-06-30
CZ287614B6 (en) 2001-01-17
HUT77605A (hu) 1998-06-29
AU703861C (en) 2001-12-20
NO970582L (no) 1997-04-07
DK0767666T3 (da) 2004-04-05
EP0767666B1 (en) 2003-12-03
BG61967B1 (bg) 1998-11-30
PT767666E (pt) 2004-04-30
HK1003709A1 (en) 1998-11-06
FI118035B (sv) 2007-06-15
NZ292315A (en) 1998-10-28
EP0767666A1 (en) 1997-04-16
JP3818660B2 (ja) 2006-09-06
BR9508584A (pt) 1997-10-21
SK282493B6 (sk) 2002-02-05
CN1158087A (zh) 1997-08-27
CA2196906A1 (en) 1996-02-22
SK17697A3 (en) 1997-09-10
PL318593A1 (en) 1997-06-23
FI970534A0 (sv) 1997-02-07
CY2514B1 (en) 2005-12-23
AU703861B2 (en) 1999-04-01
OA10598A (en) 2002-07-15
NO313786B1 (no) 2002-12-02
NO970582D0 (no) 1997-02-07
WO1996004916A1 (en) 1996-02-22
CZ37197A3 (en) 1997-10-15
DE69532239T2 (de) 2004-10-21
CN1137688C (zh) 2004-02-11
OA11737A (en) 2005-05-12
US5674855A (en) 1997-10-07
PL182043B1 (pl) 2001-10-31
DE69532239D1 (de) 2004-01-15
BG101288A (en) 1997-09-30
AP9700921A0 (en) 1997-01-31
EP0767666A4 (en) 1998-10-07
ATE255415T1 (de) 2003-12-15
JPH10504037A (ja) 1998-04-14

Similar Documents

Publication Publication Date Title
FI970534L (sv) Förfaranden och kompositioner som är användbara vid profylax och behandling av endotoxinrelaterade tillstånd
FI970918L (sv) Föreningar och förfarande för behandling av cancer
FI972260L (sv) Anordning och förfarande för behandling av ytor
HRP950499B1 (en) Compositions and methods for treating mast-cell inflammatory condition
FI963692L (sv) Förfaranden och sammansättningar användbara för inhibering av angiogenes
FI951184L (sv) Deg innefattande sammansättning och förfarande för dess framställning
GR3036364T3 (en) Compositions and methods for treating or preventing inflammatory diseases
FI971969A0 (sv) Kompositioner för behandling av hemorrojder och användningsmetod
NO20003096L (no) Sammensetninger og fremgangsmÕter for behandling av ADD
BR9509200A (pt) Composição de matéria
FI972309L (sv) 2-heterocyklyloxi- och tiometyl-1,2,5-tiadiazolidin-3-on-1,1-dioxider, kompositioner innehållande dessa och förfarande för deras framställning
DE69513916D1 (de) Oberflächenbehandlungszusammensetzung
FI972433L (sv) Rantes-peptid och fragment samt kompositioner innehållande denna lämpliga för behandling av inflammation
FI963875L (sv) Skummade rengöringskompositioner och förfarande för behandling av textiler
FI965008L (sv) Sammansättningar och förfaranden för tumörbehandling
FI951060L (sv) Formulationer och behandlingsmetoder
FI972235L (sv) Förfarande för användning av triaryletylenderivat vid behandling och förhindrande av osteoporos
BR9510062A (pt) Macromonômeto esterificado e composição
DE69520998D1 (de) Faserbehandlungszusammensetzungen
FI954245L (sv) Kompositioner och metoder för behandling av immunförmedlade inflammatoriska rubbningar
FI931612L (sv) Komposition och förfarande för inhibering av korrosion
FI942298A0 (sv) Förfarande och anordning för förflyttning av rumselementer
FI964271L (sv) Förfarande för stabilisering av föreningen DX-52-1 och lyofiliserad komposition därav
DE69708418D1 (de) Naphthylverbindungen und Zusammensetzungen
FI955123A0 (sv) Komposition innehållande kolestyramin och förfarande för framställning av densamma

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: SEPSICURE L.L.C.

FG Patent granted

Ref document number: 118035

Country of ref document: FI

MA Patent expired